PUK19 - COST-UTILITY OF SUCROFERRIC OXYHYDROXIDE FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING DIALYSIS IN CANADA
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2817
https://www.valueinhealthjournal.com/article/S1098-3015(18)36119-9/fulltext
Title :
PUK19 - COST-UTILITY OF SUCROFERRIC OXYHYDROXIDE FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING DIALYSIS IN CANADA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)36119-9&doi=10.1016/j.jval.2018.09.2817
First page :
Section Title :
Open access? :
No
Section Order :
2171